Skip to content
Menu

RBC Capital Maintains Outperform on CVS Health, Lowers Price Target to $108

Benzinga Newsdesk 12 hours ago

Analyst RatingsNewsPrice TargetHot

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

RBC Capital analyst Ben Hendrix maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $113 to $108.

RBC Capital analyst Ben Hendrix maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $113 to $108.

Read at benzinga.com